Details for New Drug Application (NDA): 078056
✉ Email this page to a colleague
NDA 078056 describes ALPRAZOLAM, which is a drug marketed by Hikma, Roxane, Actavis Elizabeth, Actavis Labs Fl Inc, Amneal Pharms Ny, Ani Pharms, Apotex Inc, Aurobindo Pharma, Heritage Pharms Inc, Impax Labs, Impax Labs Inc, Ph Health, Pharmobedient, Sandoz Inc, Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Natco, Novitium Pharma, Oxford Pharms, Sandoz, Strides Pharma Intl, Sun Pharm, and Watson Labs, and is included in thirty-six NDAs. It is available from twenty-eight suppliers. Additional details are available on the ALPRAZOLAM profile page.
The generic ingredient in ALPRAZOLAM is alprazolam. There are fifteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
The generic ingredient in ALPRAZOLAM is alprazolam. There are fifteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
Summary for 078056
| Tradename: | ALPRAZOLAM |
| Applicant: | Actavis Elizabeth |
| Ingredient: | alprazolam |
| Patents: | 0 |
Suppliers and Packaging for NDA: 078056
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 078056 | ANDA | Actavis Pharma, Inc. | 0228-3083 | 0228-3083-06 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-3083-06) |
| ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 078056 | ANDA | Actavis Pharma, Inc. | 0228-3084 | 0228-3084-06 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-3084-06) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Feb 13, 2007 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1MG | ||||
| Approval Date: | Feb 13, 2007 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 2MG | ||||
| Approval Date: | Feb 13, 2007 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
